Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MYLIP anticorps (AA 266-445)

L’anticorps Lapin Polyclonal anti-MYLIP a été validé pour IHC et ELISA. Il convient pour détecter MYLIP dans des échantillons de Humain.
N° du produit ABIN7151076

Aperçu rapide pour MYLIP anticorps (AA 266-445) (ABIN7151076)

Antigène

Voir toutes MYLIP Anticorps
MYLIP (Myosin Regulatory Light Chain Interacting Protein (MYLIP))

Reactivité

  • 40
  • 37
  • 22
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 40
  • 2
Lapin

Clonalité

  • 40
  • 2
Polyclonal

Conjugué

  • 17
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp MYLIP est non-conjugé

Application

  • 34
  • 15
  • 13
  • 12
  • 7
  • 5
  • 1
  • 1
Immunohistochemistry (IHC), ELISA
  • Épitope

    • 15
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 266-445

     Réactivité croisée

    Humain

    Purification

    Antigen Affinity Purified

    Immunogène

    Recombinant Human E3 ubiquitin-protein ligase MYLIP protein (266-445AA)

    Isotype

    IgG
  • Indications d'application

    Recommended dilution: IHC:1:20-1:200,

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène

    MYLIP (Myosin Regulatory Light Chain Interacting Protein (MYLIP))

    Autre désignation

    MYLIP

    Sujet

    Background: E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of myosin regulatory light chain (MRLC), LDLR, VLDLR and LRP8. Activity depends on E2 enzymes of the UBE2D family. Proteasomal degradation of MRLC leads to inhibit neurite outgrowth in presence of NGF by counteracting the stabilization of MRLC by saposin-like protein (CNPY2/MSAP) and reducing CNPY2-stimulated neurite outgrowth. Acts as a sterol-dependent inhibitor of cellular cholesterol uptake by mediating ubiquitination and subsequent degradation of LDLR.

    Aliases: BM-023 antibody, BZF1 antibody, E3 ubiquitin protein ligase MYLIP antibody, E3 ubiquitin-protein ligase MYLIP antibody, Idol antibody, Inducible degrader of the LDL-receptor antibody, Lipoprotein receptor antibody, MIR antibody, MYLIP antibody, MYLIP_HUMAN antibody, Myosin regulatory light chain interacting protein antibody, PP5242 antibody

    UniProt

    Q8WY64
Vous êtes ici:
Chat with us!